The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study

Clinical Therapeutics

Volumn 35, Issue 4, 2013, Pages 431-439

  Shin, Kichul ^a   Kim, Joon Wan ^b   Moon, Ki won ^c   Yang, Ji Ae ^b   Lee, Eun Yeong ^b   Song, Yeong Wook ^b   Lee, Eun Bong ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Australian Canadian Osteoarthritis Hand Index; Diacerein; Hand; Osteoarthritis

Indexed keywords

DIACEREIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ANEMIA; ARTICLE; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAND OSTEOARTHRITIS; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTOPENIA; URINE; VISUAL ANALOG SCALE;

ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; HAND; HUMANS; OSTEOARTHRITIS; PLACEBOS;

EID: 84876333268     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.02.009     Document Type: Article

References (38)

1. Lohmander L.S., Roos E.M. Clinical update: treating osteoarthritis. Lancet 2007, 370:2082-2084.
2. Fumagalli M., Sarzi-Puttini P., Atzeni F. Hand osteoarthritis. Semin Arthritis Rheum 2005, 34:47-52.
3. Dahaghin S., Bierma-Zeinstra S.M., Reijman M., et al. Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study). Ann Rheum Dis 2005, 64:99-104.
4. Leeb B.F., Sautner J., Andel I., Rintelen B. SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands. Rheumatology (Oxford) 2003, 42:1173-1178.
5. Slatkowsky-Christensen B., Mowinckel P., Loge J.H., Kvien T.K. Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data. Arthritis Rheum 2007, 57:1404-1409.
6. Michon M., Maheu E., Berenbaum F. Assessing health-related quality of life in hand osteoarthritis: a literature review. Ann Rheum Dis 2011, 70:921-928.
7. Hochberg M.C., Altman R.D., April K.T., et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012, 64:455-474.
8. Verbruggen G., Goemaere S., Veys E.M. Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs. Clin Rheumatol 2002, 21:231-243.
9. Boileau C., Tat S.K., Pelletier J.P., et al. Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling. Arthritis Res Ther 2008, 10:R71.
10. Martel-Pelletier J., Mineau F., Jolicoeur F.C., et al. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol 1998, 25:753-762.
11. Pelletier J.P., Mineau F., Fernandes J.C., et al. Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol 1998, 25:2417-2424.
12. Hwa S.Y., Burkhardt D., Little C., Ghosh P. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis. J Rheumatol 2001, 28:825-834.
13. Tamura T., Ohmori K. Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis. Eur J Pharmacol 2001, 419:269-274.
14. Smith G.N., Myers S.L., Brandt K.D., et al. Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis. Arthritis Rheum 1999, 42:545-554.
15. Rintelen B., Neumann K., Leeb B.F. A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis. Arch Intern Med 2006, 166:1899-1906.
16. Bartels E.M., Bliddal H., Schondorff P.K., et al. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage 2010, 18:289-296.
17. Fidelix T.S., Soares B.G., Trevisani V.F. Diacerein for osteoarthritis. Cochrane Database Syst Rev 2006, (1). CD005117.
18. Altman R., Alarcon G., Appelrouth D., et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 1990, 33:1601-1610.
19. Pelletier J.P., Yaron M., Haraoui B., et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum 2000, 43:2339-2348.
20. Bellamy N., Campbell J., Haraoui B., et al. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthritis Cartilage 2002, 10:855-862.
21. Bellamy N., Campbell J., Haraoui B., et al. Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthritis Cartilage 2002, 10:863-869.
22. Maheu E., Altman R.D., Bloch D.A., et al. Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthritis Cartilage 2006, 14:303-322.
23. Kvien T.K., Fjeld E., Slatkowsky-Christensen B., et al. Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis. Ann Rheum Dis 2008, 67:942-948.
24. Altman R.D., Dreiser R.L., Fisher C.L., et al. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009, 36:1991-1999.
25. Widrig R., Suter A., Saller R., Melzer J. Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study. Rheumatol Int 2007, 27:585-591.
26. Wenham C.Y., Hensor E.M., Grainger A.J., et al. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis. Rheumatology (Oxford) 2012, 51:2286-2294.
27. Moon K.W., Lee S.S., Kim J.H., et al. Cross-cultural adaptation, validation, and responsiveness of the Korean version of the AUSCAN Osteoarthritis Index. Rheumatol Int 2012, 32:3551-3557.
28. Kapoor M., Martel-Pelletier J., Lajeunesse D., et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
29. Stern A.G., de Carvalho M.R., Buck G.A., et al. Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta. Osteoarthritis Cartilage 2003, 11:394-402.
30. Nakki A., Kouhia S.T., Saarela J., et al. Allelic variants of IL1R1 gene associate with severe hand osteoarthritis. BMC Med Genet 2010, 11:50.
31. Brahmachari B., Chatterjee S., Ghosh A. Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial. Clin Rheumatol 2009, 28:1193-1198.
32. Pavelka K., Trc T., Karpas K., et al. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Arthritis Rheum 2007, 56:4055-4064.
33. Bjordal J.M., Klovning A., Ljunggren A.E., Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2007, 11:125-138.
34. Zhang W., Doherty M., Leeb B.F., et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 2009, 68:8-17.
35. Dougados M., Nguyen M., Berdah L., et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum 2001, 44:2539-2547.
36. Louthrenoo W., Nilganuwong S., Aksaranugraha S., et al. The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study. Osteoarthritis Cartilage 2007, 15:605-614.
37. Baek H., Lee E., Yoo C., et al. The study on the clinical features of gouty arthritis. Korean J Med 1997, 52:10.
38. Terkeltaub R.A., Furst D.E., Bennett K., et al. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010, 62:1060-1068.